These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
768 related items for PubMed ID: 31980183
1. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease. Grillot J, D'Engremont C, Parmentier AL, Lakkis Z, Piton G, Cazaux D, Gay C, De Billy M, Koch S, Borot S, Vuitton L. Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183 [Abstract] [Full Text] [Related]
7. Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography. Nardone OM, Ponsiglione A, de Sire R, Calabrese G, Liuzzi R, Testa A, Guarino AD, Olmo O, Rispo A, Camera L, Castiglione F. Nutrients; 2022 Aug 23; 14(17):. PubMed ID: 36079718 [Abstract] [Full Text] [Related]
8. Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study. Benjamin J, Shasthry V, Kaal CR, Anand L, Bhardwaj A, Pandit V, Arora A, Rajesh S, Pamecha V, Jain V, Kumar G, Loria A, Puri P, Joshi YK, Sarin SK. Liver Int; 2017 Nov 23; 37(11):1668-1674. PubMed ID: 29065258 [Abstract] [Full Text] [Related]
9. Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease. Boparai G, Kedia S, Kandasamy D, Sharma R, Madhusudhan KS, Dash NR, Sahu P, Pal S, Sahni P, Panwar R, Vuyyuru SK, Kante B, Yadav DP, Mouli VP, Makharia G, Ahuja V. Eur J Clin Nutr; 2021 Oct 23; 75(10):1491-1498. PubMed ID: 33531636 [Abstract] [Full Text] [Related]
10. Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia. Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, Schoeman SN, Lim A, Bartholomeusz FD, Travis SPL, Andrews JM. Nutrients; 2018 Sep 01; 10(9):. PubMed ID: 30200405 [Abstract] [Full Text] [Related]
11. Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma. Ma LX, Taylor K, Espin-Garcia O, Anconina R, Suzuki C, Allen MJ, Honorio M, Bach Y, Allison F, Chen EX, Brar S, Swallow CJ, Yeung J, Darling GE, Wong R, Kalimuthu SN, Jang RW, Veit-Haibach P, Elimova E. Cancer Med; 2021 Jan 01; 10(1):199-207. PubMed ID: 33295697 [Abstract] [Full Text] [Related]
13. Lower skeletal muscle attenuation and high visceral fat index are associated with complicated disease in patients with Crohn's disease: An exploratory study. Cravo ML, Velho S, Torres J, Costa Santos MP, Palmela C, Cruz R, Strecht J, Maio R, Baracos V. Clin Nutr ESPEN; 2017 Oct 01; 21():79-85. PubMed ID: 30014873 [Abstract] [Full Text] [Related]
14. The use of computed tomography images as a prognostic marker in critically ill cancer patients. Toledo DO, Carvalho AM, Oliveira AMRR, Toloi JM, Silva AC, Francisco de Mattos Farah J, Prado CM, Silva JM. Clin Nutr ESPEN; 2018 Jun 01; 25():114-120. PubMed ID: 29779805 [Abstract] [Full Text] [Related]
15. The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer. Chen W, Yuan Q, Li X, Yao J, Yuan L, Chen X, Gao B. Cancer Med; 2024 Jul 01; 13(13):e7452. PubMed ID: 38953401 [Abstract] [Full Text] [Related]
19. Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study. Kim SH, Kang HW, Jeong JB, Lee DS, Ahn DW, Kim JW, Kim BG, Lee KL, Oh S, Yoon SH, Park SJ. PLoS One; 2021 Jul 01; 16(8):e0256083. PubMed ID: 34403431 [Abstract] [Full Text] [Related]
20. Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Zhang T, Ding C, Xie T, Yang J, Dai X, Lv T, Li Y, Gu L, Wei Y, Gong J, Zhu W, Li N, Li J. Clin Nutr; 2017 Dec 01; 36(6):1586-1592. PubMed ID: 27814937 [Abstract] [Full Text] [Related] Page: [Next] [New Search]